glp 1 insulin resistance Frontiers GLP-1 promotes insulin secretion. |

[DOI] [PMC free article] [PubMed] [Google Scholar] 104.Cushing E.M., Chi X., Sylvers K.L., Shetty S.K., Potthoff M.J., Davies B.S.J

S., la Fleur, S

They are grounded in endogenous biology, often supported by convergent evidence across species and experimental modalities, and frequently act at integrative nodes that coordinate multiple physiological processes

While the risk of hypoglycemia is low with GLP-1 receptor agonists alone, this risk increases when combined with insulin or sulfonylureas

For more background on GLP-1 science and medical context, read a clinical overview of semaglutide here: Real-world effectiveness: what reviews and studies say Evidence base for injectable semaglutide and tirzepatide is robust, showing substantial weight loss in trials and real-world use

Frequently Asked Questions What Causes Fatigue On GLP-1 Medications